Patrick Gschwend

505 total citations
17 papers, 364 citations indexed

About

Patrick Gschwend is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Social Psychology. According to data from OpenAlex, Patrick Gschwend has authored 17 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Social Psychology. Recurrent topics in Patrick Gschwend's work include Substance Abuse Treatment and Outcomes (9 papers), Opioid Use Disorder Treatment (6 papers) and Mental Health Treatment and Access (5 papers). Patrick Gschwend is often cited by papers focused on Substance Abuse Treatment and Outcomes (9 papers), Opioid Use Disorder Treatment (6 papers) and Mental Health Treatment and Access (5 papers). Patrick Gschwend collaborates with scholars based in Switzerland, Canada and Germany. Patrick Gschwend's co-authors include Jürgen Rehm, Ambros Uchtenhagen, Félix Gutzwiller, Thomas Steffen, A. Dobler-Mikola, Bernd Schulte, Christina Hartwig, Ulrich Frick, Alexander Krämer and Gabriele Bammer and has published in prestigious journals such as The Lancet, Drug and Alcohol Dependence and European Journal of Epidemiology.

In The Last Decade

Patrick Gschwend

14 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Gschwend Switzerland 7 258 244 65 54 42 17 364
G.H.A. van Brussel Netherlands 11 257 1.0× 198 0.8× 49 0.8× 41 0.8× 46 1.1× 15 387
James Fetherston Australia 9 271 1.1× 170 0.7× 88 1.4× 89 1.6× 46 1.1× 13 424
Hugh Williams United Kingdom 8 182 0.7× 147 0.6× 44 0.7× 38 0.7× 40 1.0× 23 287
Shaun Hopkins Canada 12 353 1.4× 303 1.2× 47 0.7× 45 0.8× 37 0.9× 21 502
Richard Littlewood United Kingdom 12 238 0.9× 249 1.0× 29 0.4× 35 0.6× 39 0.9× 24 418
Susannah O’Brien Australia 8 444 1.7× 482 2.0× 62 1.0× 80 1.5× 142 3.4× 11 625
Bridie O'Reilly Australia 8 208 0.8× 114 0.5× 54 0.8× 103 1.9× 73 1.7× 13 397
Joseph Barry Ireland 13 261 1.0× 219 0.9× 26 0.4× 19 0.4× 59 1.4× 28 382
Elizabeth Khuri United States 9 233 0.9× 139 0.6× 13 0.2× 54 1.0× 65 1.5× 16 342
Chengzheng Zhao China 7 350 1.4× 174 0.7× 48 0.7× 64 1.2× 26 0.6× 8 488

Countries citing papers authored by Patrick Gschwend

Since Specialization
Citations

This map shows the geographic impact of Patrick Gschwend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Gschwend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Gschwend more than expected).

Fields of papers citing papers by Patrick Gschwend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Gschwend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Gschwend. The network helps show where Patrick Gschwend may publish in the future.

Co-authorship network of co-authors of Patrick Gschwend

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Gschwend. A scholar is included among the top collaborators of Patrick Gschwend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Gschwend. Patrick Gschwend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gschwend, Patrick, et al.. (2006). Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. European Journal of Epidemiology. 21(7). 545–549. 21 indexed citations
3.
Dürsteler‐MacFarland, Kenneth M., et al.. (2005). Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug and Alcohol Dependence. 81(3). 231–239. 20 indexed citations
4.
Rehm, Jürgen, Ulrich Frick, Christina Hartwig, et al.. (2005). Mortality in heroin-assisted treatment in Switzerland 1994–2000. Drug and Alcohol Dependence. 79(2). 137–143. 58 indexed citations
5.
Bammer, Gabriele, Wim van den Brink, Patrick Gschwend, Vincent M. Hendriks, & Jürgen Rehm. (2003). What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?. Drug and Alcohol Review. 22(3). 363–371. 16 indexed citations
6.
Gschwend, Patrick, et al.. (2003). Heroingestützte Behandlung für Opioidabhängige in der Schweiz von 1994-2001 - Inanspruchnahme und Charakteristik der Ein- und Austretenden. Das Gesundheitswesen. 65(2). 75–80. 3 indexed citations
7.
Gschwend, Patrick, et al.. (2003). Evaluating Long-Term Effects of Heroin-Assisted Treatment: The Results of a 6-Year Follow-Up. European Addiction Research. 9(2). 73–79. 54 indexed citations
8.
Gschwend, Patrick, et al.. (2003). Validität von Selbstangaben zum Drogenkonsum in der heroingestützten Behandlung in der Schweiz. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. 49(1). 24–29.
9.
Gschwend, Patrick, Jürgen Rehm, Thomas Steffen, et al.. (2003). Dosage Regimes in the Prescription of Heroin and Other Narcotics to Chronic Opioid Addicts in Switzerland – Swiss National Cohort Study. European Addiction Research. 10(1). 41–48. 15 indexed citations
10.
Gschwend, Patrick, et al.. (2003). Acht Jahre Erfahrung mit der heroingestützten Behandlung in der Schweiz – aktuelle Ergebnisse und künftige Weiterentwicklung. Therapeutische Umschau. 60(6). 355–360. 3 indexed citations
11.
Gschwend, Patrick, et al.. (2002). Development of a monitoring system for heroin-assisted substitution treatment in Switzerland. Sozial- und Präventivmedizin. 47(1). 33–38. 6 indexed citations
12.
Rehm, Jürgen, Benedikt Fischer, Michael Krausz, Patrick Gschwend, & Ambros Uchtenhagen. (2002). Heroin prescription for opioid addicts. The Lancet. 359(9309). 890–890.
13.
Gschwend, Patrick, et al.. (2002). Die Lebenssituation von Drogenabhängigen der Heroin-gestützten Behandlung in der Schweiz Eine 6-Jahres-Katamnese. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. 48(5). 370–378. 5 indexed citations
14.
Gschwend, Patrick, et al.. (2002). Konsum von Kokain vor, in und nach der heroingestützten Behandlung in der Schweiz. Suchttherapie. 3(1). 8–12. 1 indexed citations
15.
Rehm, Jürgen, Patrick Gschwend, Thomas Steffen, et al.. (2001). Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. The Lancet. 358(9291). 1417–1420. 156 indexed citations
16.
Gschwend, Patrick, et al.. (2000). Tabakprävention bei Lehrlingen - Evaluation des Praxisprojekts „Nichtrauchen ist cool!”. Das Gesundheitswesen. 62(5). 282–288.
17.
Gschwend, Patrick, et al.. (1999). Raucherentwöhnung in Apotheken — Evaluation der Raucherentwöhnungskampagne „Tabak adieu” der Apotheker/-innen beider Basel. Sozial- und Präventivmedizin. 44(1). 14–21. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026